Tag: celiac disease drugs market growth

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Celiac Disease Treatment Market Set To Climb From $0.72 Billion In 2026 To $1.02 Billion By 2030#_x000D_

The celiac disease treatment market has shown strong expansion in recent years. Its value is set to rise from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. Historically, this growth can be attributed to several factors including limited pharmacological treatment options, a reliance on gluten-free diet management, increasing diagnosis rates, greater awareness of autoimmune disorders, and improved availability of diagnostic testing._x000D_

_x000D_

The celiac disease treatment market size is anticipated to experience robust expansion over the forthcoming years. It is projected to reach $1.03 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is propelled by the development of non-dietary therapeutic options, the broadening of enzyme and immunotherapy pipelines, the increasing global prevalence of celiac disease, enhanced diagnostic accuracy, and increased healthcare spending on chronic autoimmune diseases. Significant trends expected during this period include the rising adoption of gluten-free dietary management, the ongoing development of enzyme-based therapies, an intensified focus on early diagnosis and screening, the expansion of nutritional supplement-based treatments, and greater patient awareness and disease education._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=80780633&type=smp&name=Celiac%20Disease%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Celiac Disease Treatment Market Growth Factors Behind Sustained Expansion#_x000D_

The increasing incidence of diabetes is projected to fuel the expansion of the celiac disease treatment market moving forward. Diabetes is a long-term medical condition where the body struggles to properly regulate its blood sugar or glucose levels. The rising prevalence of diabetes is linked to shared dietary management requirements, as both diabetes and celiac disease necessitate strict control over food intake to manage blood sugar and prevent associated issues. Celiac disease treatment assists diabetes by promoting a gluten-free diet, which can enhance overall digestive wellness and nutrient uptake. This helps achieve better blood sugar management and reduces complications for individuals managing both health issues. For instance, in June 2024, the National Health Service, a UK-based government department, reported that roughly 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, showing an 18% increase from 3,065,825 cases in 2022. Therefore, the growing occurrence of diabetes is acting as a catalyst for the celiac disease treatment market’s growth._x000D_

_x000D_

#Celiac Disease Treatment Market Breakdown By Product Type And Application#_x000D_

The celiac disease treatment market covered in this report is segmented – _x000D_

_x000D_

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments _x000D_

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy_x000D_

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels_x000D_

_x000D_

Subsegments:_x000D_

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins _x000D_

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations _x000D_

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents _x000D_

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies_x000D_

_x000D_

#Celiac Disease Treatment Market Industry Trends Fueling Future Revenue Growth#_x000D_

Major companies operating in the celiac disease treatment market are prioritizing the development of oral therapies, such as small molecule treatments, to offer targeted relief by blocking immune responses to gluten, enhance patient adherence, and provide alternatives to strict gluten-free diets. Small molecule therapies are minute drugs capable of easily entering cells to target and treat proteins or enzymes that cause disease. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule designed to increase endogenous glucagon-like peptide-1 (GLP-1) levels, which aids in improving intestinal barrier function in celiac disease patients. It also enhances nutrient absorption and alleviates symptoms without suppressing immune activity._x000D_

_x000D_

#Celiac Disease Treatment Market Company Landscape And Competitive Strategy#_x000D_

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX _x000D_

_x000D_

#View The Full Celiac Disease Treatment Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Celiac Disease Treatment Market Top Region: Where Does Most Revenue Come From?#_x000D_

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Celiac Disease Treatment Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The celiac disease treatment market has experienced notable expansion in recent years. Projected to rise from $0.66 billion in 2025 to $0.72 billion in 2026, with a compound annual growth rate of 9.3%, this upward trajectory reflects several key factors from the past period. These include a scarcity of pharmacological treatment choices, dependence on managing the condition through a gluten-free diet, higher diagnosis frequencies, growing public understanding of autoimmune diseases, and broader accessibility to diagnostic testing.

The celiac disease treatment market is projected to experience substantial expansion in the coming years. By 2030, it is anticipated to reach a value of $1.03 billion, with a compound annual growth rate (CAGR) of 9.2%. Factors driving this forecasted growth include the emergence of non-dietary treatment alternatives, progress in enzyme and immunotherapy research, a rising worldwide incidence of celiac disease, enhanced diagnostic precision, and greater healthcare investment in chronic autoimmune conditions. Key developments shaping the future include the growing preference for gluten-free dietary approaches, intensified efforts to create enzyme-based treatments, heightened emphasis on early detection and screening, the proliferation of nutritional supplement-based interventions, and growing patient awareness along with improved screening practices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Celiac Disease Treatment Market Industry Drivers: What Is Driving Revenue Growth?

The anticipated expansion of the celiac disease treatment market is set to be driven by the growing prevalence of diabetes. Diabetes, a chronic health condition, involves the body’s inability to properly regulate blood sugar or glucose levels. The increasing number of diabetes cases can be attributed to overlapping dietary requirements, since both diabetes and celiac disease demand strict control over food consumption to stabilize blood glucose and avoid adverse effects. Celiac disease interventions support diabetes management by encouraging a gluten-free diet, which enhances digestive health and nutrient uptake. This leads to improved blood sugar regulation and reduced risk of complications for those managing both diseases. In June 2024, the National Health Service, a UK government department, reported that approximately 3,615,330 individuals registered with a general practitioner in 2023 had a diagnosis of non-diabetic hyperglycemia or pre-diabetes, representing an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the increase in diabetes prevalence is fueling the celiac disease treatment market’s growth.

Celiac Disease Treatment Market Segment Landscape And Growth Potential

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

Celiac Disease Treatment Market Growth Trends: What Is Influencing The Future Outlook?

Leading companies within the celiac disease treatment sector are concentrating their efforts on the development of oral therapies, particularly small molecule treatments, designed to achieve targeted relief through the blockade of immune responses triggered by gluten. This approach is intended to improve patient adherence by offering a viable alternative to the strict adherence required by gluten-free diets. Small molecule therapies are pharmaceutical agents of minute size capable of easily penetrating cells to precisely target and treat proteins or enzymes responsible for disease causation. As an example, in February 2025, Immunic Inc., a biotechnology firm based in the United States, introduced IMU-856. This specific small molecule elevates levels of endogenous glucagon-like peptide-1 (GLP-1), thereby enhancing intestinal barrier function in individuals with celiac disease. Additionally, IMU-856 facilitates improved nutrient absorption and alleviates symptoms, all while avoiding the suppression of immune activity.

Celiac Disease Treatment Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Access The Complete Celiac Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Celiac Disease Treatment Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Celiac Disease Treatment Market During 2026–2030?

The celiac disease treatment market has witnessed substantial growth in recent years. Its value is projected to increase from $0.66 billion in 2025 to $0.72 billion in 2026, at a compound annual growth rate (CAGR) of 9.3%. The historic growth in this market can be attributed to various factors, including limited pharmacological treatment options, a strong reliance on gluten-free diet management, rising diagnosis rates, increased awareness of autoimmune disorders, and the growing availability of diagnostic testing.

The celiac disease treatment market size is anticipated to undergo significant expansion in the coming years. It is forecast to reach $1.03 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This projected growth is driven by the emergence of non-dietary therapeutic solutions, the broadening of enzyme and immunotherapy development pipelines, the increasing worldwide incidence of celiac disease, enhanced diagnostic accuracy, and increased financial investment in healthcare for chronic autoimmune conditions. Notable trends for the forecast period include the increasing acceptance of gluten-free dietary management, advancements in enzyme-based therapies, a heightened focus on early detection and screening, the expansion of nutritional supplement-based treatments, and greater patient understanding and education about the disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Major Factors Are Contributing To The Development Of The Celiac Disease Treatment Market?

The increasing occurrence of diabetes is projected to fuel the expansion of the celiac disease treatment market in the future. Diabetes, a chronic health condition, involves the body’s inability to properly manage blood sugar or glucose levels. The growing incidence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate precise food intake regulation to control blood sugar levels and avoid complications. Celiac disease treatment assists in managing diabetes by encouraging a gluten-free diet, which contributes to better digestive health and nutrient absorption. This approach helps achieve superior blood sugar regulation and lessens complications for people dealing with both ailments. As an illustration, in June 2024, data from the National Health Service, a UK-based government department, indicated that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes is propelling the development of the celiac disease treatment market.

Which Segment Groups Define The Celiac Disease Treatment Market Landscape?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

What Trends Are Influencing The Celiac Disease Treatment Market Outlook?

Leading companies operating in the celiac disease treatment market are focusing on creating oral therapies, including small molecule therapies. These aim to provide precise relief by inhibiting immune reactions to gluten, improving patient compliance, and offering alternatives to rigorous gluten-free diets. Small molecule therapies are tiny medications designed to readily enter cells to target and treat proteins or enzymes that cause disease. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that works by increasing endogenous glucagon-like peptide-1 (GLP-1) levels, which helps enhance intestinal barrier function in celiac disease patients. It also improves nutrient absorption and alleviates symptoms without suppressing immune activity.

Who Are The Major Companies Operating In The Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Access The Complete Celiac Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Leads The Celiac Disease Treatment Market By Size?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Celiac Disease Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Celiac Disease Treatment Market Be By 2030 Compared To Its 2026 Market Size?

The celiac disease treatment market size has shown significant expansion in recent years. Its valuation is set to climb from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate of 9.3%. The historical period’s growth can be linked to factors such as restricted pharmacological treatment alternatives, the primary reliance on gluten-free diet management, increasing rates of diagnosis, heightened awareness of autoimmune disorders, and improved availability of diagnostic testing.

The celiac disease treatment market is projected to experience robust expansion over the coming years. Its valuation is set to reach $1.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is primarily driven by the emergence of non-dietary therapeutic solutions, the broadening of enzyme and immunotherapy pipelines, an increase in the global incidence of celiac disease, enhanced diagnostic precision, and greater healthcare expenditure directed towards chronic autoimmune conditions. Key trends anticipated during this period encompass the wider acceptance of gluten-free dietary management, the evolving development of enzyme-based therapies, a heightened emphasis on early detection and screening, the diversification of nutritional supplement-based treatments, and improved patient understanding and disease education.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Key Factors Are Driving The Celiac Disease Treatment Market Growth?

The increasing occurrence of diabetes is projected to stimulate expansion within the celiac disease treatment market in the coming period. Diabetes is a long-term health condition characterized by the body’s impaired ability to manage blood sugar or glucose levels effectively. The growing incidence of diabetes stems from common dietary requirements, given that both diabetes and celiac disease necessitate strict regulation of food consumption to maintain blood sugar stability and avoid adverse outcomes. Treatment for celiac disease assists in diabetes management by advocating a gluten-free regimen, which can enhance general digestive well-being and nutrient uptake. This approach facilitates superior blood sugar regulation and minimizes complications for those dealing with both ailments. As an illustration, in June 2024, the National Health Service, a UK government body, reported that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes is fueling the expansion of the celiac disease treatment market.

How Is The Celiac Disease Treatment Market Organized By Segment Classification?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

Which Trends Are Influencing Demand In The Celiac Disease Treatment Market?

Leading companies in the celiac disease treatment market are prioritizing the creation of oral treatments, specifically small molecule therapies. These therapies aim to offer precise relief by inhibiting immune reactions to gluten, boosting patient adherence, and providing alternatives to restrictive gluten-free diets. Small molecule therapies are minute drugs that easily penetrate cells to target and address disease-causing proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, introduced IMU-856. This small molecule elevates endogenous glucagon-like peptide-1 (GLP-1) levels, which contributes to better intestinal barrier function in celiac disease patients. It also enhances nutrient absorption and eases symptoms without suppressing immune activity.

Who Are The Industry Participants Involved In The Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Get The Full Celiac Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Geographic Region Dominates The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Celiac Disease Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Celiac Disease Treatment Market From 2026 To 2030?

The celiac disease treatment market has experienced substantial growth over recent years. Its value is projected to rise from $0.66 billion in 2025 to $0.72 billion in 2026, marking a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as limited pharmaceutical treatment options, a strong dependence on gluten-free diet management, increasing rates of diagnosis, heightened awareness regarding autoimmune disorders, and improved accessibility of diagnostic testing.

The celiac disease treatment market is projected to experience significant expansion in the coming years, reaching a size of $1.03 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be attributed to several factors, including the advancement of non-dietary therapeutic choices, the broadening of enzyme and immunotherapy pipelines, an increasing global prevalence of celiac disease, enhanced diagnostic accuracy, and a rise in healthcare spending on chronic autoimmune conditions. Key trends anticipated in the forecast period involve a greater adoption of gluten-free dietary management, the ongoing development of enzyme-based therapies, an intensified focus on early diagnosis and screening, the diversification of nutritional supplement-based treatments, and increased patient awareness and education regarding the disease.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Celiac Disease Treatment Market?

The future expansion of the celiac disease treatment market is expected to be propelled by the growing incidence of diabetes. Diabetes is a chronic medical condition characterized by the body’s inability to properly regulate blood sugar or glucose levels. The increasing occurrence of diabetes is linked to shared dietary management requirements, as both diabetes and celiac disease demand careful control of food intake to manage blood sugar levels and prevent complications. Celiac disease treatment supports diabetes management through the promotion of a gluten-free diet, which can lead to improvements in overall digestive health and nutrient absorption. This approach helps achieve better blood sugar control and minimizes complications for individuals managing both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, around 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of diabetes is a significant driver for the celiac disease treatment market.

Which Segments Are Included In The Analysis Of The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

Which Trends Are Impacting The Growth Of The Celiac Disease Treatment Market?

Companies operating within the celiac disease treatment market are concentrating on developing oral therapies, including small molecule treatments. These initiatives aim to deliver targeted relief by blocking immune reactions to gluten, improving patient compliance, and presenting alternatives to strict gluten-free diets. Small molecule therapies are diminutive drugs designed to readily enter cells to target and address proteins or enzymes responsible for disease. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that increases natural glucagon-like peptide-1 (GLP-1) levels, which helps enhance intestinal barrier function in celiac disease patients. This also facilitates improved nutrient absorption and alleviates symptoms without inhibiting immune system activity.

Which Key Industry Participants Are Active In The Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Read the full celiac disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

What Are The Leading Geographic Regions In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Celiac Disease Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Celiac Disease Treatment Market From 2026 To 2030?

The celiac disease treatment market has experienced substantial growth over recent years. Its value is projected to rise from $0.66 billion in 2025 to $0.72 billion in 2026, marking a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as limited pharmaceutical treatment options, a strong dependence on gluten-free diet management, increasing rates of diagnosis, heightened awareness regarding autoimmune disorders, and improved accessibility of diagnostic testing.

The celiac disease treatment market is projected to experience significant expansion in the coming years, reaching a size of $1.03 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be attributed to several factors, including the advancement of non-dietary therapeutic choices, the broadening of enzyme and immunotherapy pipelines, an increasing global prevalence of celiac disease, enhanced diagnostic accuracy, and a rise in healthcare spending on chronic autoimmune conditions. Key trends anticipated in the forecast period involve a greater adoption of gluten-free dietary management, the ongoing development of enzyme-based therapies, an intensified focus on early diagnosis and screening, the diversification of nutritional supplement-based treatments, and increased patient awareness and education regarding the disease.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Celiac Disease Treatment Market?

The future expansion of the celiac disease treatment market is expected to be propelled by the growing incidence of diabetes. Diabetes is a chronic medical condition characterized by the body’s inability to properly regulate blood sugar or glucose levels. The increasing occurrence of diabetes is linked to shared dietary management requirements, as both diabetes and celiac disease demand careful control of food intake to manage blood sugar levels and prevent complications. Celiac disease treatment supports diabetes management through the promotion of a gluten-free diet, which can lead to improvements in overall digestive health and nutrient absorption. This approach helps achieve better blood sugar control and minimizes complications for individuals managing both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, around 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of diabetes is a significant driver for the celiac disease treatment market.

Which Segments Are Included In The Analysis Of The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

Which Trends Are Impacting The Growth Of The Celiac Disease Treatment Market?

Companies operating within the celiac disease treatment market are concentrating on developing oral therapies, including small molecule treatments. These initiatives aim to deliver targeted relief by blocking immune reactions to gluten, improving patient compliance, and presenting alternatives to strict gluten-free diets. Small molecule therapies are diminutive drugs designed to readily enter cells to target and address proteins or enzymes responsible for disease. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that increases natural glucagon-like peptide-1 (GLP-1) levels, which helps enhance intestinal barrier function in celiac disease patients. This also facilitates improved nutrient absorption and alleviates symptoms without inhibiting immune system activity.

Which Key Industry Participants Are Active In The Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Read the full celiac disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

What Are The Leading Geographic Regions In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Celiac Disease Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the celiac disease treatment market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Celiac Disease Treatment Market covering 2026–2035?

The celiac disease treatment market size has experienced significant expansion in recent years. It is projected to increase from $0.66 billion in 2025 to $0.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. The growth observed in the historic period can be attributed to factors such as limited pharmacological treatment options, the prevailing reliance on gluten-free diet management, increasing diagnosis rates, rising awareness of autoimmune disorders, and an expansion in diagnostic testing availability.

The celiac disease treatment market is projected to experience robust expansion over the coming years. This market is set to reach $1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by several factors, including the emergence of non-dietary therapeutic alternatives, the broadening of enzyme and immunotherapy pipelines, the escalating worldwide occurrence of celiac disease, enhanced diagnostic precision, and heightened healthcare expenditure on chronic autoimmune conditions. Key tendencies observed during this projection period encompass a greater uptake of gluten-free dietary management, an increase in the development of enzyme-based treatments, a heightened emphasis on early detection and screening, the diversification of nutritional supplement-based therapies, and improved patient understanding and education about the disease.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Celiac Disease Treatment Market?

The increasing prevalence of diabetes is anticipated to drive the expansion of the celiac disease treatment market. Diabetes is a persistent medical condition where the body cannot properly regulate its blood sugar or glucose levels. The rising occurrence of diabetes is attributed to common dietary management needs, as both diabetes and celiac disease demand precise control over food intake to manage blood sugar and avert complications. Celiac disease treatment assists diabetes by advocating a gluten-free diet, which can enhance overall digestive health and nutrient absorption. This contributes to better blood sugar control and fewer complications for individuals handling both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, approximately 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Thus, the escalating prevalence of diabetes is propelling the growth of the celiac disease treatment market.

What Segments Are Identified Within The Structure Of The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

What Trends Are Reshaping The Dynamics Of The Celiac Disease Treatment Market?

Leading enterprises within the celiac disease treatment market are concentrating on creating oral treatments, including small molecule therapies. These are designed to offer specific relief by inhibiting immune reactions to gluten, enhancing patient compliance, and providing options beyond strict gluten-free regimens. Small molecule therapies represent minute pharmaceuticals capable of readily penetrating cells to target and address proteins or enzymes responsible for illness. For example, Immunic Inc., a US-based biotechnology firm, introduced IMU-856 in February 2025. This small molecule functions by elevating endogenous glucagon-like peptide-1 (GLP-1) levels, which contributes to improved intestinal barrier function in individuals with celiac disease. Furthermore, it boosts nutrient absorption and lessens symptoms without suppressing the immune system.

Which Major Industry Participants Are Leading The Celiac Disease Treatment Market Growth?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Celiac Disease Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the celiac disease treatment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Celiac Disease Treatment Market Today And What Will It Reach By 2029?

The celiac disease treatment market has experienced robust expansion in recent years. It is anticipated to grow from $0.61 billion in 2024 to $0.66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. The increase observed historically can be attributed to a higher prevalence of celiac disease, greater awareness and improved diagnosis, a growing demand for non-dietary therapeutic choices, a strong array of innovative treatments in development, favorable regulatory policies, and increased financial contributions from pharmaceutical companies.

The celiac disease treatment market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the forecast period include the increasing global incidence of celiac disease, enhanced awareness and diagnosis, ongoing clinical trials exploring new treatments, a surge in demand for gluten-free options, favorable regulatory support for orphan diseases, and escalating healthcare spending. Key trends anticipated in the forecast period involve the adoption of innovative non-dietary therapies, progress in enzyme supplements, personalized medicine strategies, the creation of peptide-based immunotherapies, better diagnostic instruments, and developments in clinical trials.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What Factors Are Boosting The Celiac Disease Treatment Market?

An anticipated factor contributing to the expansion of the celiac disease treatment market is the increasing incidence of diabetes. This chronic medical condition is characterized by the body’s inability to adequately manage blood sugar or glucose levels. The growing occurrence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate meticulous regulation of food consumption for blood sugar control and complication avoidance. Celiac disease treatment offers benefits for diabetes through its encouragement of a gluten-free diet, which in turn can enhance general digestive well-being and nutrient uptake. This approach facilitates superior blood sugar management and lessens complications for individuals dealing with both ailments. As an illustration, figures from June 2024, provided by the National Health Service, a UK-based government department, reveal that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represents an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes acts as a significant impetus for the growth of the celiac disease treatment market.

How Is The Celiac Disease Treatment Market Categorized By Application, Type, And Region?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

How Are Technological Trends Affecting The Celiac Disease Treatment Market Growth?

Leading firms within the celiac disease treatment market are prioritizing the creation of oral treatments, particularly small molecule therapies. These aim to deliver specific relief by inhibiting immune reactions to gluten, enhancing patient compliance, and presenting options beyond rigorous gluten-free regimens. Small molecule therapies constitute minute pharmaceutical agents capable of readily entering cells to precisely target and address disease-triggering proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, introduced IMU-856. IMU-856 functions as a small molecule that elevates endogenous glucagon-like peptide-1 (GLP-1) levels, thereby assisting in the enhancement of intestinal barrier function in individuals with celiac disease. Furthermore, it boosts nutrient absorption and eases symptoms without suppressing immune system activity.

Who Are The Global Leaders Steering The Celiac Disease Treatment Market Forward?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2025, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Granulocyte Colony Stimulating Factors Market 2025

https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Autoimmune Disease Diagnosis Market 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Celiac Disease Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?

The celiac disease treatment market has experienced robust expansion in recent years. Its valuation is projected to rise from $0.61 billion in 2024 to $0.66 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.8%. This historical growth is driven by several factors, including an uptick in celiac disease prevalence, enhanced awareness and diagnosis rates, a rising need for non-dietary treatment alternatives, a robust array of innovative therapies in development, favorable regulatory support, and increased financial input from pharmaceutical firms.

The celiac disease treatment market is projected to experience robust expansion over the coming years. This market is anticipated to reach $0.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the forecast period include the increasing global incidence of celiac disease, enhanced awareness and diagnosis, active clinical trials for new therapies, a growing preference for gluten-free options, supportive regulatory frameworks for orphan diseases, and increased spending on healthcare. Key trends expected within the forecast period involve the adoption of innovative non-dietary treatments, improvements in enzyme supplements, customized medicine strategies, the creation of peptide-based immunotherapies, better diagnostic instruments, and progress in clinical research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Factors And Drivers Are Influencing The Celiac Disease Treatment Market In 2025?

The increasing incidence of diabetes is projected to drive the expansion of the celiac disease treatment market in the future. This condition is characterized by the body’s inability to adequately manage blood sugar or glucose levels over an extended period. The growing occurrence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate strict regulation of food intake to control blood sugar and avert complications. Celiac disease treatment supports individuals with diabetes by encouraging a gluten-free diet, which can enhance general digestive well-being and nutrient uptake. This approach contributes to improved blood sugar management and fewer complications for those dealing with both conditions. For example, data from June 2024, provided by the National Health Service, a UK government body, indicated that approximately 3,615,330 patients registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the expanding prevalence of diabetes is stimulating the growth of the celiac disease treatment market.

What Are The Leading Segments Analyzed In The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

What Long-Term Trends Will Shape The Future Growth Of The Celiac Disease Treatment Industry?

Leading firms within the celiac disease treatment market are concentrating their efforts on creating oral therapeutic options, particularly small molecule therapies. These aim to deliver specific alleviation by impeding immunological reactions to gluten, enhancing patient compliance, and presenting substitutes for rigorous gluten-free dietary restrictions. Small molecule therapies are minute pharmacological agents capable of readily entering cells to precisely address and manage pathogenic proteins or enzymes. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology firm, introduced IMU-856. IMU-856 functions as a small molecule that elevates endogenous glucagon-like peptide-1 (GLP-1) levels, thereby contributing to an enhanced intestinal barrier function in celiac disease patients. Furthermore, it boosts nutrient absorption and relieves symptoms without inhibiting immune system activity.

Which Major Firms Are Strengthening Their Position In The Celiac Disease Treatment Industry?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Celiac Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2025, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Granulocyte Colony Stimulating Factors Market 2025

https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Autoimmune Disease Diagnosis Market 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Celiac Disease Treatment Market?

The market size for celiac disease treatment has experienced robust growth recently. A rise from $0.61 billion in 2024 to an anticipated $0.66 billion in 2025, mirroring a compound annual growth rate (CAGR) of 8.8%, is predicted. This growth during the historic era is attributed to increasing incidences of celiac disease, amplified awareness and diagnosis rates, and burgeoning demand for non-dietary treatment methods. In addition, factors like the strong pipeline of pioneering therapies, favorable regulatory guidelines, and higher investments from pharmaceutical firms also contribute to the market expansion.

Predictions indicate a robust growth for the celiac disease treatment market in the upcoming years, with a forecasted surge to $0.94 billion in 2029 at a 9.3% compound annual growth rate (CAGR). The expected growth over this forecast period can be associated with the increasing global occurrence of celiac disease, heightened rates of awareness and diagnosis, ongoing clinical studies for new treatments, a rise in the demand for gluten-free options, regulatory initiatives backing orphan diseases, and the escalating costs of healthcare. The forecast period is also likely to witness major trends such as the introduction of innovative non-dietary therapies, advancements in enzyme supplements, personalized treatment strategies, development of peptide-based immunotherapies, enhanced diagnostic tools, and progress in clinical trials.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What External And Internal Drivers Are Influencing The Celiac Disease Treatment Market?

The escalation in the occurrence of diabetes is predicted to stimulate the expansion of the celiac disease treatment market in the future. Being unable to properly control blood sugar or glucose levels is a characteristic of this chronic health issue. The growing incidence of diabetes is rooted in the overlapping dietary management needs it shares with celiac disease. This includes the careful monitoring of food intake to manage blood sugar levels and to avoid complications. The adoption of a gluten-free diet in celiac disease treatment can contribute to improved digestive wellness and nutrient absorption, which in turn helps better blood sugar control and lessens complications for those managing both conditions. A case in point, in June 2024, data from the National Health Service, a UK government department, verified that around 3,615,330 individuals who registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This is an 18% climb from 3,065,825 cases in 2022. Hence, the climbing occurrence of diabetes is fuelling the growth of the celiac disease treatment market.

How Is The Celiac Disease Treatment Market Organized By Different Segments?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

What Current And Upcoming Trends Are Shaping The Celiac Disease Treatment Market?

Key players in the treatment market for celiac disease are prioritizing the development of oral treatment options, like small molecule therapies. These are intended to specifically target and neutralize immune reactions to gluten, thereby improving patient compliance and presenting an alternative to rigorous gluten-free diets. Small molecule therapies are diminutive drugs that can infiltrate cells directly in order to treat proteins or enzymes causing disease. To illustrate, Immunic Inc., a biotech corporation based in the United States introduced IMU-856 in February 2025. IMU-856 is a small molecule that amplifies the production of the glucagon-like peptide-1 (GLP-1) in our bodies, which enhances the function of the intestinal barrier in individuals with celiac disease. It also boosts the body’s capability of absorbing nutrients and reduces symptoms without negatively affecting immune activity.

Who Are The Global Leaders Steering The Celiac Disease Treatment Market Forward?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

How Do Regional Dynamics Influence The Celiac Disease Treatment Market Performance?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model